Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

In a Critical Year for Safety, AdventHealth is Rated Safest Network in Tampa Bay


“Every day, our teams make patient safety a top priority and our commitment to delivering the highest quality care is a core part of our values,” said Mike Schultz, President and CEO of AdventHealth West Florida Division.

AdventHealth West Florida Division has once again earned the highest marks possible for patient safety and quality. It is the only health care system in the Greater Tampa Bay area to achieve all A’s from the prestigious Leapfrog Group, a national nonprofit health care ratings organization.

“Every day, our teams make patient safety a top priority and our commitment to delivering the highest quality care is a core part of our values,” said Mike Schultz, President and CEO of AdventHealth West Florida Division. “We are focused on keeping our patients safe at all times while they are in our care and our ability to maintain that level of safety during a pandemic only reinforces the commitment and the expertise of our care teams.”

AdventHealth North Pinellas, AdventHealth Sebring, and AdventHealth Zephyrhills were also recognized as Top General Hospitals. AdventHealth Tampa received the Top Teaching Hospital designation and AdventHealth Wauchula earned the Top Rural Hospital designation. Only 105 of more than 2,200 hospitals reviewed were selected to receive the Top Hospitals distinction, which means they are in the top five percent across the country.

The Top Hospital designation is bestowed by The Leapfrog Group, a national non-profit watchdog organization driving a movement for quality and safety of American health care. It is widely acknowledged for setting the toughest standards for health care safety and quality.

All participating hospitals in the AdventHealth West Florida Division also received an ‘A’ or ‘B’ in patient safety from the Leapfrog Group, including:

  • AdventHealth Carrollwood – 11th consecutive ‘A’
  • AdventHealth Dade City – 1st ‘A’ (hospital acquired in April 2018)
  • AdventHealth Lake Placid – ‘B’
  • AdventHealth North Pinellas – 15th consecutive ‘A’
  • AdventHealth Ocala – ‘B’ (hospital acquired in August 2018)
  • AdventHealth Sebring – 6th consecutive ‘A’
  • AdventHealth Tampa – 6th consecutive ‘A’
  • AdventHealth Wesley Chapel – 11th consecutive ‘A’
  • AdventHealth Zephyrhills – 6th consecutive ‘A’

“These scores are reflective of our team’s commitment to consistently deliver the safest and highest quality of care possible to the communities we serve each and every day,” said Dr. Robin McGuinness, Senior Executive Officer of Patient Outcomes, AdventHealth West Florida Division.

The Safety Grade assigns an ‘A’, ‘B’, ‘C’, ‘D’ or ‘F’ grade to all general hospitals across the country and is updated every six months. It is based on a hospital’s performance in preventing medical errors, injuries, accidents, infections and other harms to patients in their care. To see full grade details and access patient tips for staying safe in the hospital, visit hospitalsafetygrade.org.

About AdventHealth West Florida Division

The West Florida Division of AdventHealth has some of the nation’s brightest medical minds making lifesaving breakthroughs with surgical pioneers, scientists and researchers using leading edge technology and innovation to deliver our brand of whole-person care. Our network of care includes AdventHealth Carrollwood, AdventHealth Connerton, AdventHealth Dade City, AdventHealth Lake Placid, AdventHealth North Pinellas, AdventHealth Ocala, AdventHealth Sebring, AdventHealth Tampa, AdventHealth Wauchula, AdventHealth Wesley Chapel and AdventHealth Zephyrhills, as well as five freestanding offsite Emergency Rooms including AdventHealth Brandon ER, AdventHealth Central Pasco ER, AdventHealth Palm Harbor ER, AdventHealth TimberRidge ER, and AdventHealth Westchase ER. We are more than hospitals, as we have a robust system of care including specialty acute care, over 200 primary care and specialty employed physicians, Express Care at Walgreens clinics, urgent care centers, wound care, physical therapy, home care, mobile mammography and more. AdventHealth is a faith-based not-for-profit health care system with a mission of Extending the Healing Ministry of Christ. AdventHealth has hundreds of care sites and nearly 50 hospitals across the United States. For more information about AdventHealth, visit AdventHealth.com, or Facebook.com/AdventHealth.

About The Leapfrog Group

Founded in 2000 by large employers and other purchasers, The Leapfrog Group is a national nonprofit organization driving a movement for giant leaps forward in the quality and safety of American health care. The flagship Leapfrog Hospital Survey and new Leapfrog Ambulatory Surgery Center (ASC) Survey collect and transparently report hospital and ASC performance, empowering purchasers to find the highest-value care and giving consumers the lifesaving information, they need to make informed decisions. The Leapfrog Hospital Safety Grade, Leapfrog’s other main initiative, assigns letter grades to hospitals based on their record of patient safety, helping consumers protect themselves and their families from errors, injuries, accidents and infections.

Share article on social media or email:

VA Palo Alto approved to build third Fisher House for Veterans and their families


“This is another great example our commitment to the needs of our Veterans and their families. We could not be prouder to be selected,” said Thomas J. Fitzgerald III, VAPAHCS Director and U.S. Army Veteran.

VA Palo Alto Health Care System (VAPAHCS) is pleased to announce it has been selected as one of 12 sites to receive its third Fisher House. These homes provide temporary housing accommodations at no charge for the families and caregivers of Veterans and active duty Service Members receiving VA Care. A timeline for construction of the new Fisher House has not been established.

“This is another great example our commitment to the needs of our Veterans and their families. We could not be prouder to be selected,” said Thomas J. Fitzgerald III, VAPAHCS Director and U.S. Army Veteran.

The new Fisher House will support access to care for thousands of additional Veterans traveling to VAPAHCS for treatment and is an addition to the existing Fisher House 1 and Fisher House 2, featuring 21 and 20 rooms respectively. They both feature a common kitchen, laundry facilities, spacious dining room and an inviting living room with library, and toys for children. The houses are 100% handicap accessible and include elevators.

“One of the best parts of Fisher House, and I think the most touching, is what happens inside of Fisher Houses. Lifelong bonds are made with the families all going through similar situations and they really support one another during difficult times,” said Tracy Marino, Fisher House Manager for the existing two Fisher Houses on campus.

VA shares a long and successful relationship with Fisher House Foundation that saw the first build in 1994, aiming to provide “a home away from home” for families of patients receiving medical care at VA medical centers. Upon completion of construction by the Fisher House Foundation, the houses are donated to VA, who assumes responsibility for the operation, maintenance, upkeep, and staffing. As of April 2020, there are 46 Fisher Houses located at VA medical facilities across the nation.

Veterans and families can learn more about the VAPAHCS Fisher Houses and eligibility by visiting http://www.paloalto.va.gov/services/fisherhouse.asp. For more information on the VA Fisher House Program, visit http://www.socialwork.va.gov/fisher.asp.

Share article on social media or email:

SpectraMedix VBP Performance Analytics Version 3 Powers Payer-Provider Success in Value-Based Arrangements


News Image

SpectraMedix VBP Performance Analytics V3 enables health plans and their providers to work together to proactively identify, intervene, and close the loop on the core areas that impact cost, performance, and outcomes

Today SpectraMedix, a leading provider of solutions that advance and align Value-Based Payment (VBP) models for health plans and providers, announced the release of VBP Performance Analytics Version 3. The latest release delivers newly enhanced analytics capabilities that help providers improve performance based on value-based payment contracts. It also features advanced AI and Machine Learning technologies that fuel a new level of actionable insight for payers and providers.

“SpectraMedix VBP Performance Analytics V3 enables health plans and their providers to work together to proactively identify, intervene, and close the loop on the core areas that impact cost, performance, and outcomes,” said Raj Lakhanpal, MD, Chief Executive Officer at SpectraMedix. “It supports Commercial, Medicare Advantage, Medicare, and Medicaid business lines across the entire spectrum of VBP types.”

Integrated into SpectraMedix VBP Performance Analytics Version 3 is the ability to track quality measure results, identify gaps in measures, and receive recommended interventions. Interventions are based on HEDIS guidelines and can be tailored to specific incentive programs.

Here are just a few of the new features in SpectraMedix VBP Performance Analytics Version 3:

The ability for providers to generate reports at the practice/TIN and provider/NPI level, enhancing their ability for self-improvement.

Financial incentive visibility that shows performance and compensation in near real-time.

Drug and medical utilization metrics, analytics, and reporting to facilitate closure of VBP indicators and determine network performance against contracts.

Actionable insights into the utilization and cost of services under prescription drug benefits associated with attributed members.

Clinically-validated interventions integrated into clinician workflows for closing care and measure gaps.

A risk-adjusted provider report card that shows progress and comparison to peer and professional benchmarks to help providers improve.

Predictive risk models that provide aggregate level summaries and the ability to target at-risk members.

SpectraMedix VBP Performance Analytics Version 3 is one of four applications that comprise the VBP Performance Suite, seamlessly integrating with the VBP Contract Modeler, Cohort Manager, and Self-Service Analytics. It is built upon the SpectraMedix Platform, a HIPAA compliant, NCQA certified framework that is the cornerstone of all SpectraMedix applications.

VBP Performance Analytics Version 3 Product Showcase on January 13, 2020

SpectraMedix is hosting a VBP Performance Analytics Version 3 Showcase Webinar on January 13, 2020 at 1:00 PM EDT. This is an exclusive event open to the payer and provider communities. If you would like an invitation, please request an invite at https://www.spectramedix.com/vbp-performance-analytics-version-3-showcase.

Share article on social media or email:

LM Medical NYC recognized as a 2020 Top Patient Rated NYC Plastic Surgeon/Dermatologist by Find Local Doctors


News Image

We are so honored to be recognized by Find Local Doctors. Our goal is to help patients feel and look their best at any age by providing exceptional cosmetic surgery and skin care treatments, says Dr. Lesley Rabach

LM Medical NYC was recently recognized by Find Local Doctors as a 2020 Top Patient Rated New York City Plastic Surgeon/Dermatologist. Whether you are seeking non-surgical medical treatment for acne or want to explore cosmetic surgery, LM Medical NYC offers the best of both worlds in one facility. As a result of excellent online reviews and five-star ratings across multiple sources, LM Medical NYC has been recognized with this impressive honor. Find Local Doctors is a user-friendly online directory that helps consumers connect with experienced physicians in their area. LM Medical NYC joins a distinguished group of medical practitioners that have earned this title.

As sisters and founders of the practice, Dr. Lesley Rabach, a board-certified facial plastic surgeon, and Dr. Morgan Rabach, a board-certified dermatologist, come together to provide the highest-quality medical, surgical and cosmetic care for patients. At LM Medical NYC, patients receive the benefit of access to two top physicians in their respective medical fields, all at one state-of-the-art facility. Combining expertise in facial plastic surgery and dermatology, the practice provides a customized approach to meet each patient’s personal needs. LM Medical NYC has created a comfortable, upscale atmosphere, providing many services, ranging from the latest in clinical dermatology treatments to non-invasive cosmetic injections and youthful makeovers with plastic surgery.

“We are so honored to be recognized by Find Local Doctors. Our goal is to help patients feel and look their best at any age by providing exceptional cosmetic surgery and skincare treatments,” says Dr. Lesley Rabach.

More about LM Medical NYC:

LM Medical NYC’s clinic is located at 33 Fifth Avenue #1B in New York, NY, and offers cutting-edge cosmetic surgery and skincare treatments The practice offers expertise in two fields of medicine to help patients achieve the appearance they desire at their clinic on 5th Avenue in Manhattan. Dr. Lesley Rabach is double board-certified in two facial plastic surgery fields, with a stellar reputation for creating natural, exquisite results for patients. Her extensive education, training and experience have earned accolades in her field, and she has been published in various medical journals. Dr. Morgan Rabach is a board-certified dermatologist who also has been recognized for her many accomplishments in dermatology and aesthetics. She has received many top rankings in her field and has a substantial media presence in some of the top beauty publications around the world. For more information or to schedule a consultation or appointment, please call 212-777-2272, or visit http://www.lmmedicalnyc.com.

Share article on social media or email:

United Breast Cancer Foundation Reports Success of Gift-in-Kind Program During COVID-19 Pandemic


UBCF provides useful, high-quality donated products to breast cancer patients, families and those in need during COVID-19 pandemic. Donations valued over $12 Million Dollars.

UBCF provides useful, high-quality donated products to breast cancer patients, families and those in need during COVID-19 pandemic. Donations valued over $12 Million Dollars.

UBCF has donated over $12 Million in useful, high-quality products to breast cancer patients, families and those in need during COVID-19 pandemic!

United Breast Cancer Foundation (UBCF), a GuideStar Platinum rated charity, is proud to share news of the overwhelming success of their Gift-in-Kind (GIK) Program. UBCF has provided over $12 Million dollars worth of high-quality and useful products to breast cancer patients, families and those in need. Whether it be Tempur-Pedic® mattresses, hand sanitizer, face masks, makeup, clothing, shoes, daily essentials, or even a pick-me-up Pink Bag full of gifts, UBCF has helped people all across the nation. UBCF has delivered products to those in need and will continue to be there, now and throughout the COVID-19 pandemic, through the support of Gifts-in-kind.

Every kind of giving is valuable when it comes to your heart, but one to keep in mind is in-kind. In-kind gifts are contributions of goods or services, other than a financial donation. A gift-in-kind can help UBCF assist the thousands of patients and survivors that turn to them for services and support, AND help donors be more generous than they might have been able to do otherwise during this pandemic. To make an in-kind contribution to UBCF, email GIKProgram@ubcf.org.

Moira, a UBCF client recently received a king size mattress. “Picking up my Tempur-pedic mattress was an early Christmas present that brought tears to my eyes. I already slept on it and had the best night’s sleep. I want to thank all involved who helped to make this gift possible for me. As a breast cancer survivor I have had many sleepless nights and I am sure this mattress will enable me to have many restful nights in the years to come. UBCF made the pick up so easy and had all your helpers ready to assist my husband to put in our truck. Both of us were so appreciative! I want to thank all of you for the work you do in bringing joy to all of us who have endured breast cancer and wish you a joyous holiday season!”

Gifts-in-kind mean lower costs for UBCF so more funds can be directed to patient and family programs, assisting more women, men and families nationwide. UBCF programs include: Individual Grant, Holistic Care, Community Service, Child Sponsorship, Breast screening, Breast Reconstructive Surgery and the Audrey B. Mastroianni College Scholarship.

Executive Director Stephanie Mastroianni shared, “During these uncertain times, UBCF has been working hard to answer the call of our patients, their families and those in need across the country. Thanks to the people and communities’ amazing support, we’ve been able to assist more than 300 patients and their families with nearly $240,000 in products through our COVID-19 Emergency Assistance Program which helps ease the burden of cancer patients sheltering at home.”

1 in 8 women will be diagnosed with breast cancer in their lifetime. Per the National Cancer Institute (NCI), over 40,000 women and men will lose their lives to this deadly disease each year. Early detection of breast cancer helps save lives. UBCF encourages women and men to learn the self breast exam, available at no cost here. Please visit ubcf.org for more information.

About UBCF

UBCF is committed to offering breast health and wellness services focused on cancer prevention, screening, treatment and overall wellness. UBCF’s mission is to make a positive difference in the lives of those affected by breast cancer and does so through seven life-supporting patient and family programs available to women, men and families nation-wide. UBCF never denies services to anyone regardless of age, race, gender, ethnicity, income or medical insurance coverage. Tax-deductible contributions may be made towards UBCF’s programs. UBCF accepts Donor Advised Fund contributions and vehicle donations as well. Combined Federal Campaign #77934. https://www.ubcf.org

Share article on social media or email:

How to Keep Older Loved Ones Safe this Holiday Season


While the pandemic will certainly impact how the holidays are observed this year, that does not mean families should abandon traditions. There are ways to celebrate, bring cheer and include older family members in a way that is memorable and enjoyable while keeping everyone safe.

The holidays are a joyous time, and there is no reason that should change because of this year’s challenges. While traditionally this is a time for families to come together in person, we need to consider the health of older loved ones and find new ways to safely celebrate and keep traditions alive.

According to AARP, about 64% of family caregivers expect to change their typical holiday traditions, and 77% say the pandemic will affect their plans at least to some extent. While many seniors look forward to this time of year, cooking big meals, decorating their home and participating in traditions like watching holiday movies or caroling with family, now is the time to protect them, even if that means adjusting in-person traditions.

“As seniors age, their time spent with family, especially through holiday activities such as cooking dinner and decorating the tree, becomes even more precious,” said Lakelyn Hogan, Ph.D., gerontologist and caregiver advocate at Home Instead. “That is, especially as seniors may be feeling more isolated and lonely than ever due to COVID-19, it will be important to not simply cancel these events, but simultaneously identify new ways to safely celebrate with the older adults in our lives this year.”

While the pandemic will certainly impact how the holidays are observed this year, that does not mean families should abandon traditions. There are ways to celebrate, bring cheer and include older family members in a way that is memorable and enjoyable while keeping everyone safe. Hogan offers the following tips on ways to safely spend the holidays with seniors this year:

1. Host a virtual family celebration. To get into the holiday spirit, host a tree-decorating celebration together via video conference, have everyone decorate their tree at the same time and share photos of the final product. On the big day, enjoy a meal together over video, or keep traditions alive by video chatting with your senior loved ones when opening gifts.

2. Deliver a meal. Many families are unable to gather this year. Consider cooking a meal and delivering it to the doorstep of older loved ones, or even do a contactless exchange of divided meal items along with holiday greetings from afar.

3. Start a movie marathon. Propose a holiday movie marathon and encourage loved ones to watch at the same time from the comfort of their own home. You can connect over video conference or text to enjoy your favorite scenes together as they happen, or call afterwards to discuss your favorite part.

4. Drive-by parades. If you’re feeling virtual fatigue, opt for a safe, socially-distanced celebration option to brighten a loved one’s holiday. Create festive posters or deck your car out like a parade float and drive by their home to bring the holidays to them. You’ll be able to see their smiling faces while still maintaining a safe distance.

5. Send care packages. Send a holiday care package with nods to your favorite holiday traditions. If you’re used to decking the halls together, include a few of your favorite ornaments or swap fireplace stockings. You can also send family favorite holiday films and freshly baked cookies to make them feel included in the usual festivities.

Just because older loved ones may be celebrating separately this holiday season does not mean they have to celebrate alone. By connecting in new festive and creative ways, you can ensure that the spirit of the season is not lost.

For more tips and ideas on safely celebrating the holidays and keeping your loved one healthy and safe, visit http://www.caregiverstress.com/senior-activities/holidays/.

###

ABOUT HOME INSTEAD

Founded in 1994 in Omaha, Nebraska, the Home Instead® franchise network provides personalized care, support and education to enhance the lives of aging adults and their families. Today, the network is the world’s leading provider of in-home care services for older adults, with more than 1,200 independently owned and operated franchises that provide more than 80 million hours of care annually throughout the United States and 13 other countries. Local Home Instead offices employ approximately 90,000 CAREGiversSM worldwide who provide basic support services that enable older adults to live safely and comfortably in their own homes for as long as possible. Home Instead franchise owners partner with clients and their family members to help meet varied individual needs. Services span the care continuum – from providing personal care to specialized Alzheimer’s care and hospice support. Also available are family caregiver education and support resources. Visit HomeInstead.com. Connect with us on Facebook and Twitter.

Share article on social media or email:

CURIS System Wins Approval from Government of Canada For Hard-Surface Disinfecting System that Fights COVID-19


The portable CURIS Decontamination System for SARS-CoV-2 (COVID-19)

The ability to not only disinfect a space thoroughly and effectively and prove and continually improve those efforts through our proprietary cloud-based reporting system, brings companies and the public the reassurance and peace of mind they deserve in these uncertain times

Along with the Government of Canada’s issuance of an “urgent need for health products that can help limit the spread of microorganisms, including viruses that cause COVID-19,” it announced inclusion of CURIS System’s proprietary CURoxide™ Hydrogen Peroxide blend and fogging system in its list of hard-surface disinfectants that are now authorized for sale in Canada to be used in the fight against SARS-CoV-2 (COVID-19). CURoxide shows a measurable 99.9999% efficacy in killing the most resistant pathogens*.

This interim approval came as a result of Health Canada introducing innovative and agile regulatory measures to increase supply and ensure Canadians and health care workers have access to hand sanitizers, disinfectants and personal protective equipment to address product shortages. Among other measures, Health Canada publishes an up-to-date list of disinfectants approved for use against COVID-19, in which it has included CURIS’ CURoxide.

CURIS’ CURoxide™ Hydrogen Peroxide blend and fogging system is also the only pulse fogging system on the United States Environmental Protection Agency (EPA)’s List-N for efficacy against SARS-CoV-2 (COVID-19). CURoxide has been in use for more than 7 years to stop the spread of infectious disease in commercial settings across the world, including currently in use by the National Guard to decontaminate ambulances, police stations, daycare facilities and more; by public transportation systems, including Portland’s TriMet to disinfect buses every evening after service; in public school systems, including Seminole County, Florida, to disinfect classrooms and other public spaces; by municipal fire departments, such as Miami Fire EMS for their fire trucks; the Georgia Department of Emergency Preparedness; and many more.

“Too many products on the market today make unsubstantiated claims that result in ineffective or improper decontamination against the virus but also can potentially harm the materials and surfaces they are used on as well as prove toxic to the people administering the chemicals,” said Frances Grinstead, CEO of CURIS System. “Having already gone through the rigorous testing and application process with the EPA and to now be approved for sale and use by Health Canada, CURIS can give customers the peace of mind that the safety of its product, its delivery mechanism, and its effectiveness in fighting COVID and other disease is unmatched in the industry.”

While most systems rely on dispensing chemicals and turning off once the desired time is achieved or depend on manual spraying, CURIS goes a step further by focusing on a ‘maintained pathogen-kill zone.’ Its system is designed to reduce human error with a hands-free system for remote operation that allows the operator to monitor, manage, measure, track, and report, including the ability to quickly prove, and continuously improve, decontamination efforts. Traditional cleaning methods, even others approved for COVID-19, often miss surface areas, and many disinfectants that kill 99.9% of germs can leave up to 1,000 harmful organisms behind on surfaces. This was once considered acceptable but not any longer with the onset of COVID-19. Other commercial solutions on the market today have been proven to leave behind dangerous, toxic residues that collect grime and cause corrosion to surfaces, materials, electronics and more. Many of these chemical residues have been linked to neurotoxicity, allergies and anti-microbial resistance in humans.

The CURIS Decontamination System was designed and is manufactured in the U.S.A. to effectively work in such environments as:

  • Transportation systems, including buses, airplanes, subways, taxis
  • Emergency Response Operations, including fire stations, police stations
  • Schools
  • Medical facilities, including hospitals, assisted living/long-term care facilities
  • Laboratory spaces
  • Sports facilities and gyms
  • Military facilities

“The ability to not only disinfect a space thoroughly and effectively and prove and continually improve those efforts through our proprietary cloud-based reporting system, brings companies and the public the reassurance and peace of mind they deserve in these uncertain times,” added Grinstead.

About CURIS® System

Headquartered in Oviedo, Florida, CURIS System provides the most efficacious pulse germ-killing* disinfectant system with no harmful residues available on the market today. Established in 2014, CURIS’ innovative and patented hydrogen peroxide fogging system has revolutionized portable, high-level disinfection, making hospital-grade decontamination accessible across multiple markets. Its EPA-registered “No Touch” disinfection system uses pulse hydrogen peroxide fog to kill germs and odors. The system is easy to use, portable (roll-behind or hand carry), non-corrosive and leaves behind NO harmful residues. The CURIS app can be used for remote activation and cloud-based data storage for optimal tracking, management and reporting. For more information, please visit http://www.curissystem.com

*c.diff in a tri part soil load

Share article on social media or email:

Real Food Blends Launches 4th Annual 12 Days of Holiday Magic Campaign


12 Days of Holiday Magic by Real Food Blends

12 Days of Holiday Magic by Real Food Blends

We’re honored to give back to the people who have done so much for us and highlight their amazing stories through 12 Days of Holiday Magic. It’s our hope that these uplifting stories bring some much needed hope and holiday cheer. — Tony Bombacino, Co-Founder and President, Real Food Blends

Real Food Blends, makers of 100% real food meals for people with feeding tubes, and the company that started a real food revolution in the medical community, is excited to announce its 4th Annual 12 Days of Holiday Magic. As a way to thank its customers and advocates for their overwhelming support, the company will be giving away cases of their meals every day for 12 straight days. In addition, Real Food Blends is donating 5% of their daily website sales each day to a different charity that is related to the tube feeding community.

“This year has been challenging for everyone, and it’s the consistent support of our customers that has enabled us to thrive and operate as we always have to provide the benefits of 100% real food and nutritional variety to people with feeding tubes,” said Tony Bombacino, Co-Founder and President of Real Food Blends. “We’re honored to give back to the people who have done so much for us and highlight their amazing stories through 12 Days of Holiday Magic. It’s our hope that these uplifting stories bring some much needed hope and holiday cheer.”

Each day during 12 Days of Holiday Magic, a different customer story will be featured on Real Food Blends’ Facebook page and that person will receive two free Variety 12-Packs of Real Food Blends meals as a thank you for sharing their story. Two randomly selected people from the company’s Facebook community will also receive a free Variety 12-Pack of RFB meals. In addition, the company will also donate 5% of its website sales to a different charity that has ties to the feeding tube community.

Customers throughout the country have shared their stories for this year’s campaign, including Al, a cancer survivor in New York who was able to get back to his love of hiking and even hiked a 272-mile trail after switching to Real Food Blends, and Michele in California whose son’s seizures decreased once he started using RFB.

“We’ve seen the difference real food has made with our son, AJ, and it’s the biggest honor of our lives to be able to bring the power of real food to people of all ages with feeding tubes,” said Julie Bombacino, Co-Founder and CEO of Real Food Blends. “We thank our customers for their unending support and for taking the time to share their stories with us about the difference Real Food Blends has made in their lives.”

12 Days of Holiday Magic starts today and continues through December 25, 2020. More details can be found on the company’s Facebook page, Facebook.com/RealFoodBlends, and all the customer stories, videos, and more can be found at RealFoodBlends.com/HolidayMagic.

ABOUT REAL FOOD BLENDS

Real Food Blends makes 100% real food meals for people with feeding tubes. Born from Julie and Tony Bombacino’s love for their own son with a feeding tube and a belief that we all deserve real food and nutritional variety, the meals are free of corn syrup and preservatives, are shelf-stable, and covered by many insurance plans. With millions of meals sold, they are available nationwide through DMEs, medical supply and home infusion companies or direct via RealFoodBlends.com and Amazon.

Share article on social media or email:

Little Sparrows Technologies bili•hut™ Phototherapy Trial Lights the Way for Outpatient Treatment of Infant Jaundice


bili•hut™ neonatal phototherapy system

Our practice is very impressed by how effective bili•hut is compared to biliblanket phototherapy in treating jaundice. It is easy to administer, shortens the time required for phototherapy and keeps infants with their families safe at home.

Little Sparrows Technologies, a medical startup committed to improving the care and well-being of newborns, announces initial results of a home phototherapy trial of bili•hut™, a next-generation portable LED phototherapy device for neonatal jaundice treatment. In this first series consisting of three infants, bili•hut was deployed directly from a primary care pediatric office following outpatient diagnosis of significant jaundice. The infants were effectively treated at home in an average of 16 total hours of phototherapy treatment and did not require hospital readmission.    

Currently conducted in the greater Boston area, the bili•hut trial is designed to deliver hospital intensity phototherapy at home for the treatment of neonatal jaundice (NNJ). Jaundice is the leading reason newborns are readmitted into a hospital. It is a yellow discoloration of the skin and eyes caused by elevation of bilirubin, a breakdown product of red blood cells. Approximately 10 percent of all newborns suffer from elevated bilirubin levels which can cause irreversible brain injury or death if untreated. Phototherapy treatment using high intensity blue light helps with the detoxification of bilirubin, curing nearly all cases of jaundice and preventing brain injury.

“During a pandemic it is more critical than ever to have access to effective and convenient outpatient phototherapy treatment of neonatal jaundice. It keeps infants and families out of the hospital and safe at home,” said Dr. Scott Blanchard, senior attending physician at Bulotsky and Associates, a Mass General Brigham Affiliated Pediatric Practice in the greater Boston area using bili•hut.

“Our practice is very impressed by how effective bili•hut is compared to biliblanket phototherapy in treating jaundice. It is easy to administer, shortens the time required for phototherapy and keeps infants with their families safe at home,” continued Dr. Blanchard.

Bili•hut™ Trial Results

The first two infants in the trial had blood type mismatch resulting in destruction of infant red blood cells. In less than 48 hours after arriving home from birth, both infants experienced sudden increases of serum bilirubin to ranges meeting the American Academy of Pediatrics criteria for phototherapy treatment, despite reassuring levels during their birth admission. The third infant had neonatal jaundice associated with polycythemia, or high red blood cell count. After receiving two courses of intensive care unit phototherapy during birth admission the infant was discharged home, only to again experience significant elevation of bilirubin 24 hours later.

In consultation with their pediatric office, the parents received a portable bili•hut bassinet and training. The parents were able to effectively administer phototherapy treatment at home. The bili•hut achieved bilirubin reduction rates ranging from 0.35 mg/dL/hr to 0.58/dL/hr, resolving jaundice with an average of 16 total hours of phototherapy.

The results are on par with hospital intensive care unit phototherapy devices despite frequent interruptions in the home setting. They also dramatically outpace the performance of fiberoptic pad devices, or “biliblankets”, which can require four or more days of treatment in uncomplicated jaundice cases and are generally inadequate for the more complicated cases seen in the bili•hut trial.

“The early results of our home care bili•hut trial are extremely exciting,” said Dr. Donna Brezinski, CEO of Little Sparrows Technologies and a neonatologist. “About 200,000 newborns are readmitted to the hospital in the United States every year for phototherapy treatment. With the efficacy we are seeing with bili•hut, it is very promising that a home treatment option could be available through pediatric offices for the majority of jaundice cases. This would greatly reduce the cost of care and enable better use of hospital resources, while keeping mom and baby together during a critical time of bonding and establishing breastfeeding.”

For more information on the bili•hut, visit http://www.little-sparrows-tech.com.

About bili•hut™

Jaundice is the most common diagnosis associated with hospital readmission of newborns, costing the US healthcare system more than $1B annually. Bili•hut™, is a first-of-its-kind portable high-intensity phototherapy device for jaundice treatment offering a unique, arched light configuration that increases skin illumination by at least 50 percent compared to traditional phototherapy devices. Capable of delivering amongst the highest spectral power of any neonatal phototherapy device available, bili•hut offers hospital intensity treatment at the parent’s side, whether in the postpartum room or home.

About Little Sparrows Technologies

Founded in 2013 by Harvard Medical School affiliated physicians, Little Sparrows Technologies offers an innovative approach for treating jaundice. Little Sparrows has received two phases of funding from the National Institutes of Health Small Business Innovation Research (SBIR) program as well as from the USAID sponsored Saving Lives at Birth Grand Challenge. Little Sparrows Technologies received a 2018 Patents for Humanity Award recognizing the potential for bili•hut to be a game-changing technology to solve a humanitarian challenge. The company offers solutions to support hospitals, US pediatrician offices and international health care organizations. For more information, http://www.little-sparrows-tech.com.

Share article on social media or email:

PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization


Carterra LSA Instrument

We are thrilled to have PerkinElmer as an investor and look forward to working together to advance our shared visions to improve drug discovery and life science research.

Carterra, Inc., the world leader in label-free high throughput antibody screening and characterization, today announced that they have closed on a round of equity financing led by PerkinElmer, Inc. Current Carterra investors Telegraph Hill Partners and Ballast Point Ventures also participated in the financing round.

The Carterra LSA™ platform for accelerating the discovery of therapeutic antibodies has become the new standard in many of the largest pharmaceutical companies in the world, as well as leading biotech, academic, CRO and government research labs. The Carterra LSA platform is also being used in COVID-19 therapeutics research including by CoVIC, the worldwide consortium funded by The Bill & Melinda Gates Foundation. The LSA platform enables 100 times the binding data to be collected in 10% of the time with 1% of the sample versus competing platforms.

“Biologics and biotherapeutics discovery and development is a very dynamic area of pharma science and one that is important to PerkinElmer’s strategy as we work with scientists around the world to help them develop new ways to fight chronic disease and outbreaks like COVID-19,” said Dr. Alan Fletcher, VP and GM Life Sciences at PerkinElmer. “Carterra’s innovative high throughput SPR (surface plasmon resonance) technology is poised to disrupt biologics research in the areas of both upstream profiling and downstream QA/QC.”

Traditional antibody discovery relies on low-resolution screening techniques to triage antibody libraries down to a small number of candidates, which are then characterized on low-throughput biosensors. The Carterra LSA platform turns that model on its head by allowing the rapid and high-resolution characterization of entire antibody libraries for binding kinetics and epitope, thereby combining screening and characterization into one step. This saves significant time, money, and precious samples. It also reduces the risk of missing a potential blockbuster candidate. Biologics developers now have an enormous advantage in differentiating their molecules from competitors’ drugs and establishing intellectual property claims.

“The LSA platform is the state of the art in biologics discovery,” said Josh Eckman, Carterra’s Chief Executive Officer. “We are thrilled to have PerkinElmer as an investor and look forward to working together to advance our shared visions to improve drug discovery and life science research.”

About Carterra, Inc.

Carterra® is the leading provider of high throughput technologies designed to accelerate and improve the discovery of novel therapeutic candidates. Carterra’s LSA™ instrument, software, and consumables for monoclonal antibody (mAb) characterization deliver up to 100 times the throughput of existing platforms in 10% of the time while using only 1% of the sample required by other systems. The LSA combines patented microfluidics technology with real-time high throughput Surface Plasmon Resonance (HT-SPR) and industry-leading data analysis and visualization software to revolutionize mAb screening. Carterra, Inc. is based in Salt Lake City, Utah, and has Customer Experience Centers in San Francisco, Salt Lake City, Boston, and Munich, Germany. For additional information, please visit http://www.carterra-bio.com.

About PerkinElmer

PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of more than 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $2.9 billion in 2019, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at http://www.perkinelmer.com.

Share article on social media or email: